| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/06/2002 | US6428966 Growth differentiation factor, lefty-1 |
| 08/06/2002 | US6428958 Testing a biological sample for a gene encoding canine rpe65 comprising a nucleotide sequence according to seq id no. 1 having an aaga deletion mutation of nucleotides 487-490 |
| 08/06/2002 | US6428954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 08/06/2002 | US6428953 Retrovirus vectors; plasmids; gene delivery; genetic engineering; human immunodeficiency virus |
| 08/06/2002 | US6428951 Comprising reassembly of separate fragments of monomeric enzyme wherein reassembly of monomeric enzyme fragments is operated by interaction of molecular domains fused to each monomeric enzyme fragment |
| 08/06/2002 | US6428949 Human phosphatase inhibitor protein |
| 08/06/2002 | US6428792 Linear amino acid sequences from viral core, e1, e2, ns3, ns4, and ns5 regions; excellent sensitivity and specificity for immunoassay of antibodies; screening body fluids such as blood |
| 08/06/2002 | US6428790 Using viricidal polypeptides on solid supports for prophylaxis of human t-cell leukemia/lymphoma virus; antibodies |
| 08/06/2002 | US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction |
| 08/06/2002 | US6428781 Composition of an endogenous insulin-like growth factor-II derivative |
| 08/06/2002 | US6428324 Vaccine |
| 08/06/2002 | CA2130832C Virus-targeted biocatalysts |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA2057010C Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 08/06/2002 | CA1341381C Yeast hybrid vectors and their use for the production of polypeptides |
| 08/06/2002 | CA1341380C Process for the preparation of n-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides |
| 08/05/2002 | WO2003079746A2 A novel human g-protein coupled receptor, hgprbmy14, related to the orphan gpcr, gpr73 |
| 08/05/2002 | CA2440930A1 A novel human g-protein coupled receptor, hgprbmy14, related to the orphan gpcr, gpr73 |
| 08/02/2002 | WO2001055207A1 Nucleic acids, proteins, and antibodies |
| 08/02/2002 | CA2395738A1 Nucleic acids, proteins, and antibodies |
| 08/01/2002 | WO2002060163A2 Methods for increasing bone formation and enhancing bone accretion |
| 08/01/2002 | WO2002059621A2 Regulation of transthyretin to treat obesity |
| 08/01/2002 | WO2002059613A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 08/01/2002 | WO2002059612A2 Animal model and cell-line expressing modified chlorine channel |
| 08/01/2002 | WO2002059606A2 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection |
| 08/01/2002 | WO2002059604A2 Diagnosis and treatment of multiple sclerosis |
| 08/01/2002 | WO2002059381A2 Gene for identifying individuals with familial dysautonomia |
| 08/01/2002 | WO2002059377A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | WO2002059369A2 Compositions and methods for the treatment of diseases related to faulty cholesterol regulation |
| 08/01/2002 | WO2002059349A2 Odorant receptors and uses thereof |
| 08/01/2002 | WO2002059346A2 Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents |
| 08/01/2002 | WO2002059345A2 Nucleic acid encoding ion transporter component protein |
| 08/01/2002 | WO2002059344A2 Gpr54 g protein-coupled receptor |
| 08/01/2002 | WO2002059339A1 Process for producing cytochrome c |
| 08/01/2002 | WO2002059337A1 Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 08/01/2002 | WO2002059336A2 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector |
| 08/01/2002 | WO2002059334A1 Vectors capable of imparting herbicide resistance and viral cross protection and methods |
| 08/01/2002 | WO2002059332A2 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof |
| 08/01/2002 | WO2002059331A1 In vivo mutation and recombination in filamentous fungi |
| 08/01/2002 | WO2002059321A2 Hepatitis c virus replicons and replicon enhanced cells |
| 08/01/2002 | WO2002059320A2 Dna sequences of escherichia coli cft073 |
| 08/01/2002 | WO2002059319A1 Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 08/01/2002 | WO2002059317A2 Cub domain protein zcub3 and materials and methods for making it |
| 08/01/2002 | WO2002059316A2 Human ion exchanger proteins and polynucleotides encoding the same |
| 08/01/2002 | WO2002059315A2 Human nucleic acids and polypeptides and methods of use thereof |
| 08/01/2002 | WO2002059314A2 A human melanoma associated antigen and uses therefor |
| 08/01/2002 | WO2002059313A2 G-protein coupled receptors and nucleic acids encoding same |
| 08/01/2002 | WO2002059312A2 Cell adhesion proteins |
| 08/01/2002 | WO2002059311A2 Colon cancer marker |
| 08/01/2002 | WO2002059310A2 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | WO2002059309A2 Anthozoa derived chromoproteins, fluorescent mutants thereof and methods for using the same |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059307A2 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof |
| 08/01/2002 | WO2002059306A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/01/2002 | WO2002059304A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/01/2002 | WO2002059303A1 Nurr1 transcription factor i-box mutants having monomeric transcriptional activation activity |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059301A1 Chemokines |
| 08/01/2002 | WO2002059299A2 Expression cloning method |
| 08/01/2002 | WO2002059298A2 Gab2(p97) gene and methods of use thereof |
| 08/01/2002 | WO2002059293A2 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 08/01/2002 | WO2002059292A2 Functional balanced-lethal host-vector systems |
| 08/01/2002 | WO2002059291A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | WO2002059283A2 Nucleic acid modification enzymes |
| 08/01/2002 | WO2002059282A2 Adipocyte complement related protein zacrp13 |
| 08/01/2002 | WO2002059281A2 High level cytokine production with enhanced cell viability |
| 08/01/2002 | WO2002059275A2 39362, a novel human cub domain-containing protein family member and uses thereof |
| 08/01/2002 | WO2002059274A2 Mosquito olfactory gene, polypeptides, and methods of use thereof |
| 08/01/2002 | WO2002059268A2 Factor ixa: factor viiia interaction and methods therefor |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059266A2 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor |
| 08/01/2002 | WO2002059264A2 Specific human antibodies for selective cancer therapy |
| 08/01/2002 | WO2002059263A2 Transgenic animals comprising a humanized immune system |
| 08/01/2002 | WO2002059261A2 Inhibition of restenosis using a dna-coated stent |
| 08/01/2002 | WO2002059260A2 Nucleic acids and polypeptides |
| 08/01/2002 | WO2002059258A2 Chimeric proteins for prevention and treatment of hiv infection |
| 08/01/2002 | WO2002059257A2 Method and means for producing barley yellow dwarf virus resistant cereal plants |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059255A2 Protein-protein interactions in $i(saccharomyces cerevisiae) |
| 08/01/2002 | WO2002059248A2 A novel gene associated with regulation of adiposity and insulin response |
| 08/01/2002 | WO2002059156A2 Therapeutic compounds structurally-linked to bacterial polypeptides |
| 08/01/2002 | WO2002059153A2 Anticoagulants and their uses |
| 08/01/2002 | WO2002059152A2 Vr-oac, an osmotically activated channel protein, nucleic acids encoding it, and uses thereof |
| 08/01/2002 | WO2002059151A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 08/01/2002 | WO2002059150A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 08/01/2002 | WO2002059149A2 Pro-apoptotic proteins and dna molecules encoding them |
| 08/01/2002 | WO2002059148A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | WO2002059147A2 Activatable cytolytic or drug delivery peptides and uses thereof |
| 08/01/2002 | WO2002059146A2 Peptides having affinity for the gp120 viral protein and use thereof |
| 08/01/2002 | WO2002059143A2 Therapeutic peptides for demyelinating conditions |
| 08/01/2002 | WO2002059140A2 Ikaros rgulatory elements and uses thereof |
| 08/01/2002 | WO2002058735A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | WO2002058729A2 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | WO2002058727A2 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine |
| 08/01/2002 | WO2002058723A2 Chemokines as adjuvants of immune response |
| 08/01/2002 | WO2002058721A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | WO2002058719A1 Methods and compositions using cap43 proteins and nucleic acids to diagnose and treat cancer and other disorders |
| 08/01/2002 | WO2002058717A2 Methods for treating rheumatoid arthritis using il-17 antagonists |
| 08/01/2002 | WO2002058716A2 Treatment of inflammatory bowel disease using growth factors |
| 08/01/2002 | WO2002058638A2 Serpin drugs for treatment of hiv infection and method of use thereof |